Pretax income is the income that a company earns before paying income taxes. Edwards Lifesciences's pretax income for the
three
months ended in Dec. 2023 was $422 Mil.
Its pretax income for the trailing twelve months (TTM) ended in Dec. 2023 was $1,598 Mil.
Edwards Lifesciences's pretax margin was 27.49%.
During the past 13 years, Edwards Lifesciences's highest Pretax Margin was 49.25%. The lowest was 20.45%. And the median was 26.72%.
Edwards Lifesciences Pre-Tax Income Historical Data
The historical data trend for Edwards Lifesciences's Pre-Tax Income can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of Edwards Lifesciences's Pre-Tax Income
For the Medical Devices subindustry, Edwards Lifesciences's Pre-Tax Income, along with its competitors' market caps and Pre-Tax Income data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Edwards Lifesciences's Pre-Tax Income Distribution in the Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Edwards Lifesciences's Pre-Tax Income distribution charts can be found below:
* The bar in red indicates where Edwards Lifesciences's Pre-Tax Income falls into.
Edwards Lifesciences Pre-Tax Income Calculation
This is the income that a company earns before paying income taxes.
Edwards Lifesciences's Pretax Income for the fiscal year that ended in Dec. 2023 is calculated as
Pre-Tax Income for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $1,598 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Edwards Lifesciences (NYSE:EW) Pre-Tax Income Explanation
Edwards Lifesciences's Pretax Margin for the quarter that ended in Dec. 2023 is calculated as
During the past 13 years, Edwards Lifesciences's highest Pretax Margin was 49.25%. The lowest was 20.45%. And the median was 26.72%.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Edwards Lifesciences Pre-Tax Income Related Terms
Thank you for viewing the detailed overview of Edwards Lifesciences's Pre-Tax Income provided by GuruFocus.com. Please click on the following links to see related term pages.
Edwards Lifesciences (Edwards Lifesciences) Business Description
Spun off from Baxter International in 2000, Edwards Lifesciences designs, manufactures, and markets a range of medical devices and equipment for advanced stages of structural heart disease. It has established itself as a leader across key products, including surgical tissue heart valves, transcatheter valve technologies, surgical clips, catheters, and monitoring systems used to measure a patient's heart function during surgery. The firm derives about 55% of its total sales from outside the U.S.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
EW has been successfully added to your 